Self
Should Australia Subsidize Antiobesity Drugs?
The use of GLP-1 agonists such as Wegovy, Ozempic, and Mounjaro is rapidly rising in Australia, but their high costs are fueling debate over whether
The use of GLP-1 agonists such as Wegovy, Ozempic, and Mounjaro is rapidly rising in Australia, but their high costs are fueling debate over whether
CHICAGO — A post-market study of the retina drug faricimab (Vabysmo), focusing exclusively on minority populations often underrepresented in clinical trials, revealed that Hispanic and
A major new study suggests that no amount of alcohol is safe for brain health, with even light drinking linked to an increased risk of
A large systematic review and meta-analysis has found that short courses of systemic corticosteroids (≤14 days) in children are associated with a small but significant
We’ve gotten incredibly good at curing illness—but somewhere along the way, we forgot how to truly recover. In his article “What We’ve Forgotten About Getting
For many physicians, the day begins before sunrise, often with no time for self-care. It’s a whirlwind of early appointments, surgeries, admin meetings, and a
A study conducted in Bangkok, Thailand, found that light-intensity walking can lower postprandial glucose levels and diastolic blood pressure in young adults with obesity, with
Using a cell phone for at least one call per week increases the risk of cardiovascular disease (CVD), especially among smokers and people with diabetes,
A new phase 3 clinical trial published in Nature Medicine has found that VER-01, a full-spectrum Cannabis sativa extract, significantly reduces pain and improves sleep
We all know that many teenagers have access to cannabis, and a large number of them, at least once, have tried it. A late study